Cancer

A large study of nearly 16,000 adults found no link between eating animal protein and higher death risk. Surprisingly, higher animal protein intake was associated with lower cancer mortality, supporting its role in a balanced, health-promoting diet.

Kate Middleton, in remission since January 2025, has unofficially stepped back from duties due to emotional and physical struggles.

A new study suggests that novel CRISPR gene editing boosts natural killer cell function in cancer treatment.

Kate Middleton's blonde transformation at Balmoral sparks speculation about her cancer update and signals a fresh chapter in her royal journey.

A meta-analysis did not find any correlation between pathologic complete response and overall survival or disease-free survival in patients with rectal cancer.

Researchers have long known that cancer alters its genome as it evolves. What has been less clear is

Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men.

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future.

Researchers from Kyoto Prefectural University of Medicine and collaborating Japanese institutions found that patients carrying colibactin-producing Escherichia coli (pks+ E. coli) in their colon polyps were more than three times as likely to have a history of colorectal cancer compared to those without the bacterium.

A new research paper was published in Volume 16 of Genes & Cancer on August 6, 2025, titled "Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in HeLa cells."

After the predictive probability of achieving superiority with mFOLFIRINOX or S-IROX was less than 1%, the trial was terminated due to futility.

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer.

A phase 3 trial suggests reducing the use of cisplatin when treating nasopharyngeal carcinoma with toripalimab-based chemoradiotherapy is noninferior to using standard treatment.

Scientists developed a fast DNA damage test for radiation that could guide cancer care and help responders deliver personalized treatment during radiological emergencies.

Patients with solid tumors, including breast and lung cancers, showed only slightly less accurate results. In contrast, individuals with blood cancers, particularly chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), sometimes had large errors, with ages overestimated by as much as 50 years.

Adding a focal boost to standard external beam radiotherapy improves biochemical disease-free survival in patients with localized prostate cancer, long-term data confirm.

Scientists at the National Institute of Standards and Technology (NIST) have developed a new technology for measuring how radiation damages DNA molecules. This novel technique, which passes DNA through tiny openings called nanopores, detects radiation damage much faster and more accurately than existing methods. It could lead to improved radiation therapy for cancer and more personalized care for individuals during radiological emergencies.

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.

Natural killer (NK) cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from The University of Texas MD Anderson Cancer Center.

From virtual counselors that can hear depression creeping into a person's voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients with breast cancer.

TTFields plus chemotherapy significantly prolonged overall survival compared with chemotherapy alone in patients with pancreatic cancer.

A telephone-based weight loss program leads to meaningful 1-year weight loss in women with stage II/III breast cancer and obesity.

NICE has recommended enfortumab vedotin plus pembrolizumab as a new first-line treatment for advanced urothelial cancer.

Scientists have finally uncovered the missing link in how our bodies absorb queuosine, a rare micronutrient crucial for brain health, memory, stress response, and cancer defense. For decades, researchers suspected a transporter had to exist, but it remained elusive—until now.

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than standard forms of chemotherapy.

Emily Long's shocking decision to kill her family has left investigators searching for answers. Her TikTok posts suggest her husband's cancer battle may have taken a devastating mental toll.

While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.

A preclinical evaluation of a new 'dual-mode' tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery.

UCSF scientists caught cancer cells in the act of breaking into fat cells and releasing their fat. The energy heist seems to be critical for the growth of deadly breast cancer.

Judge Frank Caprio, beloved for his compassionate rulings on Caught in Providence, has died at 88 following a battle with pancreatic cancer.

The retrospective study is the largest to evaluate the relationship between dose-averaged LET profiles and local control after CIRT for pancreatic cancer.

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to new research from The University of Texas MD Anderson Cancer Center.

An international, interdisciplinary research team led by Prof. Jakob N. Kather from the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology analyzed seven independent patient cohorts from Europe and the USA using their newly developed AI model.

Scientists are piecing together how cannabis smoke may disarm the body's immune arsenal while activating cancer-linked pathways. But the potential links aren't yet completely understood.

Newer treatments and expanded screening are allowing more people to live for many years after cancer treatment, a welcome advance that poses unique considerations for primary care clinicians.

Scientists have uncovered a hidden weakness in one of the deadliest childhood cancers. The tumors, which spread quickly and are notoriously hard to treat, rely on a sugar-processing pathway to survive and grow. By blocking this pathway, researchers were able to slow down the cancer and make it more vulnerable to treatment. This breakthrough opens the door to new therapies for children and young adults facing a disease with very few options today.

Radiotherapy with ADT outperforms radical prostatectomy strategies in reducing the risk for distant metastasis but results in similar overall survival in patients with high-risk prostate cancer.

In a new study, long-distance runners were significantly more likely to have dangerous polyps in their colon than expected.

The most common cancer-causing strain of human papillomavirus (HPV), HPV16, undermines the body's defenses by reprogramming immune cells surrounding the tumor, according to new research from the Keck School of Medicine of USC.

A new research paper was published in Volume 17, Issue 7 of Aging (Aging-US) on July 7, 2025, titled "Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer."

A small, preliminary study found that marathoners were much more likely to have precancerous growths. Experts aren’t sure why.

A small, preliminary study found that marathoners were much more likely to have precancerous growths. Experts aren’t sure why.

University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to better find tumors through tracing magnetic fluid injected in the body.

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is

A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers. Unlike traditional vaccines designed to target specific tumor proteins, this approach simply revs up the immune system as if it were fighting a virus. The results were dramatic—when paired with checkpoint inhibitors, tumors shrank, and in some cases, the vaccine alone wiped them out.

Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the reliability and accuracy of artificial intelligence (AI) for many applications. As an example, they apply the new method to early cancer detection from blood samples, known as liquid biopsy.

Patients with local or regional cutaneous squamous cell carcinoma are randomly assigned to receive cemiplimab or placebo post-op.

A new study delving into the genetic drivers of a rare and aggressive childhood cancer called Malignant Peripheral Nerve Sheath Tumor (MPNST) has revealed metabolic frailties in the cancer cells that might be exploited to improved treatments for patients.

Cancer patients can regain full health with immunotherapy. Now researchers are hunting for the perfect immune cell with the help of a very special robot.

Phase 1 data may support continued research of amphiphile lymph node-targeted immunotherapy in solid tumors.

The mitochondria may be the powerhouse of the cell, but mounting evidence suggests this organelle is also a driving force behind cancer.

Certain types of biochemical processes can impair the immune system's ability to recognize and kill cancer cells. Purdue University's W. Andy Tao and his associates have developed a new way to study these processes. They demonstrated the validity of their method in experiments involving leukemia and rare liver cancer cell lines.

MONDAY, Aug. 18, 2025 — Nike co-founder Phil Knight and his wife, Penny, will donate $2 billion to Oregon Health & Science University (OHSU) to expand cancer research and patient care.The school called it the largest single donation ever made t...

A team of scientists at the Garvan Institute of Medical Research has discovered that inactivation of a stress pathway makes ER+ breast cancer cells ignore stress signals, allowing them to evade treatment.

By combining high-res imaging tools with light-absorbing nanostars, researchers can more precisely treat cancerous tumors.

Cancer remains one of the most challenging diseases to treat, as conventional therapies like chemotherapy and radiotherapy are often hindered by poor specificity, systemic toxicity, and damage to healthy tissues.

Biomedical engineers at Duke University have developed a method to more precisely heat up gold nanoparticles to target and destroy cancerous tumors. Using imaging methods that combine light and sound to peer deeper into tissue, the team was better able to track and heat up nanoparticles to destroy a bladder cancer tumor in an animal model. The research is published in the journal Science Advances.

A higher intake of cruciferous vegetables may be associated with a lower risk for colon cancer, a meta-analysis of 17 studies shows.

Bacterial decolonization with mupirocin nasal ointment slashes rates of severe acute radiation oral mucositis in patients with nasopharyngeal carcinoma, new data find.

Novel risk assessment model improves transplant decision-making and helps customize treatments for older patients with blood cancer.

Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC) representing the most treatment-resistant subtype due to limited therapeutic targets and frequent relapse.

Researchers at Columbia Engineering have built a cancer therapy that makes bacteria and viruses work as a team.

A whistleblower who resigned as a nurse from the Royal Belfast Hospital for Sick Children says staff shortages at a cancer unit are not new.

Tumor electrophysiological abnormalities, characterized by membrane potential dysregulation, ion channel network remodeling, and microenvironmental signaling interactions, are critical drivers of malignancy.

A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy.

Outcomes favoring robotic surgery for CRC may be influenced by patient selection factors, including clinical stability.

Scientists have engineered a groundbreaking cancer treatment that uses bacteria to smuggle viruses directly into tumors, bypassing the immune system and delivering a powerful one-two punch against cancer cells. The bacteria act like Trojan horses, carrying viral payloads to cancer’s core, where the virus can spread and destroy malignant cells. Built-in safety features ensure the virus can’t multiply outside the tumor, offering a promising pathway for safe, targeted therapy.

Cancer Research UK-funded scientists have uncovered dementia-like behaviour in pancreas cells at risk of turning into cancer. The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a difficult-to-treat disease linked to 6,900 deaths in the UK every year.

After chemotherapy, some people get "chemo curls" and other changes to their hair texture and appearance. But why?

A new case report was published in Volume 12 of Oncoscience on July 28, 2025, titled "A rare case of pure non-gestational ovarian choriocarcinoma: Diagnostic mimicry and management strategies."

Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, described the excitement of seeing novel molecules like antibody drug conjugates become more prominent.

Tristan Rogers, beloved General Hospital star, died at 79 following a brief fight with lung cancer. Discover details of his diagnosis, career legacy and final days.

Mnt News RSS Feed

Recent advancements in cancer research are shedding light on a novel therapeutic strategy aimed at overcoming the formidable challenge of cancer stem cells (CSCs).

Mnt News RSS Feed

Irish fashion designer Martha Nolan-O'Slatarra's death remains under investigation as detectives question whether she had brain cancer, with toxicology tests and a second autopsy underway in the US.

Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy.

An AI system can identify high-risk areas on interval breast cancer screening mammograms and detect tumours that radiologists miss, a Swiss study shows.

Virus-based treatments are already approved to treat several types of cancer, and combining them with bacteria could make them even more effective

Buckingham Palace issues rare update on King Charles's cancer, confirming ongoing treatment and positive progress while keeping details private.

Respiratory viruses such as influenza and COVID-19 can reactivate dormant breast cancer cells in the lungs, raising the risk of metastasis. The process is driven by IL-6–induced cell changes and immune suppression, with the highest recurrence risk soon after infection.

Oregon Health & Science University said the couple’s donation would be the largest single gift to a higher-learning institution in the United States.

Tran Ho, DO, FSSO, FACS, discussed how she found her passion in breast surgical oncology and how her mentors helped her achieve success.

The cells could be a new source of tumor DNA for liquid biopsies

The human papillomavirus (HPV) can cause six types of cancer.

The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a life-threatening syndrome responsible for over one-third of cancer-related deaths.

Determining whether a cancerous tumor originated in a given location or spread there from another tissue or organ in the body is important when assessing the likely course of a patient's disease.

The Knight Foundation said the gift that will be used to shift the scientific approach to cancer treatment, research and patient care outcomes.

In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line setting for metastatic castration-resistant prostate cancer.

New data show that the new CDK4/6 inhibitor with fulvestrant yields a notable PFS benefit in HR+/HER2- advanced breast cancer but at the cost of more toxicities.

US counties with persistently low cervical cancer screening have up to 96% higher mortality and 83% higher incidence of this cancer than high-screening counties, a new study finds.

A third of people don’t even know this STD exists, a new study finds.

A major global study of 2.5 million people found that alcohol consumption is linked to a modest but real increase in pancreatic cancer risk.

According to a study by Karolinska Institutet, nearly three times as many people under the age of 50 in Sweden are diagnosed with colorectal cancer today compared with the early 1990s.

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage.

Inspired by his immigrant grandfather in West Virginia, who stayed healthy in old age, a City of Hope hematologist has helped develop more nuanced care for older patients with blood cancer.